Paper17513708
Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial).
Umpierrez GE and 7 others. Diabetes Care, 2007. Cited by 481 papers, by iCite.
Cite this record
ConductScience Library. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Papers, record 17513708. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17513708
- Disease
- type 2 diabetes mellitus613 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial).
- PubMed
- Publication types
- Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus, Type 2 | Major topic |
| Hyperglycemia | Major topic |
| Hypoglycemic Agents | Major topic |
| Insulin | Major topic |
| Adult | |
| Aged | |
| Female | |
| Hospitalization | |
| Humans | |
| Insulin Glargine | |
| Insulin, Long-Acting | |
| Male | |
| Middle Aged | |
| Prospective Studies | |
| Treatment Outcome |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| M01 RR-00039 | NCRR NIH HHS | United States | M01RR000039 | PubMed and NIH | NIH RePORTER |
| R03 DK073190-01 | NIDDK NIH HHS | United States | R03DK073190 | PubMed and NIH | NIH RePORTER |
Trials9
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT00394407 | Basal/Bolus Versus Sliding Scale Insulin In Hospitalized Patients With Type 2 Diabetes | Derived from the trial | Yes | ClinicalTrials.gov |
| NCT00911625 | Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency | Background | ClinicalTrials.gov | |
| NCT01136746 | Hospital Management of Hyperglycemia Study of Insulin Glargine Plus Insulin Lispro Versus Human Regular Insulin | Background | ClinicalTrials.gov | |
| NCT01855243 | Comparison on Efficacy and Safety of Three Inpatient Insulin Therapy in Type2 DM | Background | ClinicalTrials.gov | |
| NCT02758522 | NPH and Regular Insulin in the Treatment of Inpatient Hyperglycemia: Comparison of 3 Basal-bolus Regimens | Background | ClinicalTrials.gov | |
| NCT03455985 | Effectiveness of a Diabetes Focused Discharge Order Set Among Poorly Controlled Hospitalized Patients Transitioning to Glargine U300 Insulin | Background | ClinicalTrials.gov | |
| NCT05752929 | Comparison of 2 Hyperglycemia-correction Scales in Hospitalized Patients | Results | ClinicalTrials.gov | |
| NCT06206525 | Feasibility Trial Using an Inpatient Insulin Dosing Calculator | Background | ClinicalTrials.gov | |
| NCT06638567 | Postoperative Basal Bolus or Sliding Scale Insulin Regimen in DM2 and Its Effect on Surgical Site Infections. | Background | ClinicalTrials.gov |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 17726192 | Sliding-scale insulin: more evidence needed before final exit? | https://conductscience.org/library/papers/17726192 |
Source PubMed
Cited by222
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 481 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42979027 | Alogliptin-Pioglitazone and Insulin Regimen for Inpatient Glycemic Control: A Randomized Continuous Glucose Monitoring Pilot Trial. | AACE Endocrinol Diabetes | 2026 | https://conductscience.org/library/papers/42979027 | PubMed |
| 42162480 | [Hospital diabetes management (Update 2026)]. | Wien Klin Wochenschr | 2026 | https://conductscience.org/library/papers/42162480 | PubMed |
| 42018146 | Time delays between fingerstick glucose measurements and correctional insulin administration in the hospital: do they really matter? | Diabetologia | 2026 | https://conductscience.org/library/papers/42018146 | PubMed |
| 41840510 | Feasibility of continuous glucose monitoring in an acute geriatric unit - the GLYCOGER study. | BMC Geriatr | 2026 | https://conductscience.org/library/papers/41840510 | PubMed |
| 41467154 | Implementation of a Multihospital Electronic Medical Record-Based Insulin Order Set to Reduce Hypoglycemic Events. | AACE Endocrinol Diabetes | 2025 | https://conductscience.org/library/papers/41467154 | PubMed |
| 40828947 | Evaluating Intensive Insulin Therapy With Empagliflozin in Type 2 Diabetes: A Randomised Study. | Endocrinol Diabetes Metab | 2025 | https://conductscience.org/library/papers/40828947 | PubMed |
| 40823595 | Inpatient Insulin Dosing Calculators. | Diabetes Spectr | 2025 | https://conductscience.org/library/papers/40823595 | PubMed |
| 40631460 | 2025 Clinical Practice Guidelines for Diabetes Management in Korea: Recommendation of the Korean Diabetes Association. | Diabetes Metab J | 2025 | https://conductscience.org/library/papers/40631460 | PubMed |
| 40554622 | Novel Inpatient Automated Self-Adjusting Subcutaneous Insulin Algorithm: 3-Year Experience. An Observational Study. | J Clin Endocrinol Metab | 2026 | https://conductscience.org/library/papers/40554622 | PubMed |
| 40396304 | Continuous glucose monitoring during intravenous insulin infusion treatment: Assessing accuracy to enable future clinical utility. | Diabet Med | 2025 | https://conductscience.org/library/papers/40396304 | PubMed |
| 40369552 | Use of an insulin titration protocol based on continuous glucose monitoring in postoperative cardiac surgery patients with type 2 diabetes and prediabetes: a randomized controlled trial. | Cardiovasc Diabetol | 2025 | https://conductscience.org/library/papers/40369552 | PubMed |
| 40014293 | In-Hospital Management of Hyperglycemia: The Role of Insulin Degludec. | Diabetes Ther | 2025 | https://conductscience.org/library/papers/40014293 | PubMed |
| 39939862 | Screening and management of hospital hyperglycemia in non-critical patients: a position statement from the Brazilian Diabetes Society (SBD). | Diabetol Metab Syndr | 2025 | https://conductscience.org/library/papers/39939862 | PubMed |
| 39884508 | Association Between Daily Insulin Dose Adjustments and Glycemic Control in Noncritically Ill Hospitalized Hyperglycemic Patients: A Retrospective Cohort Study. | Endocr Pract | 2025 | https://conductscience.org/library/papers/39884508 | PubMed |
| 39694328 | Randomized Study Comparing Continuous Glucose Monitoring and Capillary Glucose Testing in Patients With Type 2 Diabetes After Hospital Discharge. | Endocr Pract | 2025 | https://conductscience.org/library/papers/39694328 | PubMed |
| 39091005 | 2023 Clinical Practice Guidelines for Diabetes Management in Korea: Full Version Recommendation of the Korean Diabetes Association. | Diabetes Metab J | 2024 | https://conductscience.org/library/papers/39091005 | PubMed |
| 38950348 | Starting Insulin Algorithms for Noncritical Illness: A Survey of 32 Academic Hospitals in the United States. | Diabetes Technol Ther | 2024 | https://conductscience.org/library/papers/38950348 | PubMed |
| 38919469 | Real-world community hospital hyperglycemia management in noncritically ill, type 2 diabetic patients: a comparison between basal-bolus insulin and correctional insulin. | J Pharm Pharm Sci | 2024 | https://conductscience.org/library/papers/38919469 | PubMed |
| 38756429 | Glycemic Management in Insulin-Naive Patients in the Inpatient Setting. | Diabetes Spectr | 2024 | https://conductscience.org/library/papers/38756429 | PubMed |
| 38560900 | Management of Inpatient Elevated Blood Pressures : A Systematic Review of Clinical Practice Guidelines. | Ann Intern Med | 2024 | https://conductscience.org/library/papers/38560900 | PubMed |
Drugs3
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets | Source |
|---|---|---|---|---|---|
| INSULIN GLARGINE | CHEMBL1201497 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL1201497 | ChEMBL |
| INSULIN GLULISINE | CHEMBL1201613 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL1201613 | ChEMBL |
| INSULIN HUMAN | CHEMBL1201631 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL1201631 | ChEMBL |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- References
- Genes
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17513708
GET https://conductscience.org/api/papers/v1/17513708/cited_by?page=2